Listed

Cellectis S.A.: Form 20-F for the period ended Dec 31, 2020

Filed with the SEC on Mar 4, 2021 and accepted by EDGAR at Mar 4, 2021, 16:51 ET.

Share

Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2020-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue12 months2020-01-01 to 2020-12-31$73.9mifrs-full:Revenue
Cost of revenue12 months2020-01-01 to 2020-12-31$36.3mifrs-full:CostOfSales
Operating income12 months2020-01-01 to 2020-12-31−$85.4mifrs-full:ProfitLossFromOperatingActivities
Income tax12 months2020-01-01 to 2020-12-31$0ifrs-full:IncomeTaxExpenseContinuingOperations
Net income12 months2020-01-01 to 2020-12-31−$81.1mifrs-full:ProfitLossAttributableToOwnersOfParent
Diluted EPS12 months2020-01-01 to 2020-12-31−$1.91ifrs-full:DilutedEarningsLossPerShare
Basic EPS12 months2020-01-01 to 2020-12-31−$1.91ifrs-full:BasicEarningsLossPerShare
Operating cash flow12 months2020-01-01 to 2020-12-31−$80.3mifrs-full:CashFlowsFromUsedInOperatingActivities
Capital expenditure12 months2020-01-01 to 2020-12-31$45.7mifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
Cash and equivalentsAt period end2020-12-31$241.1mifrs-full:CashAndCashEquivalents
Current assetsAt period end2020-12-31$315.4mifrs-full:CurrentAssets
Total assetsAt period end2020-12-31$469.5mifrs-full:Assets
Current liabilitiesAt period end2020-12-31$52.0mifrs-full:CurrentLiabilities
Shareholders' equityAt period end2020-12-31$275.6mifrs-full:EquityAttributableToOwnersOfParent
Shares outstandingAt period end2020-12-3142,780,186 sharesdei:EntityCommonStockSharesOutstanding

Source: SEC EDGAR, the filing index for accession 0001193125-21-069635. Last ingested by Listed: Nov 14, 2026, 10:50 ET. Listed shows no prices and gives no investment advice.